# AEGLEA BIOTHERAPEUTICS INC (AGLE)

> Institutional ownership reported to the SEC as of Q1 2024, from Form 13F filings. Source: https://holderbook.com/stocks/AGLE/

- Reporting holders: 1
- Reported value: $16.4M
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Yu Fan](https://holderbook.com/funds/1668029-yu-fan/) | $16.4M | 737,000 | 22.7% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q1 2024 | 1 | $16.4M |
| Q3 2023 | 3 | $351.4M |
| Q2 2023 | 41 | $31.9M |
| Q1 2023 | 41 | $11.9M |
| Q4 2022 | 47 | $19.2M |
| Q3 2022 | 50 | $23.5M |
| Q2 2022 | 59 | $26.3M |
| Q1 2022 | 80 | $95.4M |
| Q4 2021 | 86 | $190.1M |
| Q3 2021 | 77 | $322.6M |
| Q2 2021 | 79 | $289.1M |
| Q1 2021 | 85 | $329.0M |